MACOP-B regimen: Difference between revisions

	WikiDoc Resources for MACOP-B regimen
Articles
Most recent articles on MACOP-B regimen Most cited articles on MACOP-B regimen Review articles on MACOP-B regimen Articles on MACOP-B regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on MACOP-B regimen Images of MACOP-B regimen Photos of MACOP-B regimen Podcasts & MP3s on MACOP-B regimen Videos on MACOP-B regimen
Evidence Based Medicine
Cochrane Collaboration on MACOP-B regimen Bandolier on MACOP-B regimen TRIP on MACOP-B regimen
Clinical Trials
Ongoing Trials on MACOP-B regimen at Clinical Trials.gov Trial results on MACOP-B regimen Clinical Trials on MACOP-B regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on MACOP-B regimen NICE Guidance on MACOP-B regimen NHS PRODIGY Guidance FDA on MACOP-B regimen CDC on MACOP-B regimen
Books
Books on MACOP-B regimen
News
MACOP-B regimen in the news Be alerted to news on MACOP-B regimen News trends on MACOP-B regimen
Commentary
Blogs on MACOP-B regimen
Definitions
Definitions of MACOP-B regimen
Patient Resources / Community
Patient resources on MACOP-B regimen Discussion groups on MACOP-B regimen Patient Handouts on MACOP-B regimen Directions to Hospitals Treating MACOP-B regimen Risk calculators and risk factors for MACOP-B regimen
Healthcare Provider Resources
Symptoms of MACOP-B regimen Causes & Risk Factors for MACOP-B regimen Diagnostic studies for MACOP-B regimen Treatment of MACOP-B regimen
Continuing Medical Education (CME)
CME Programs on MACOP-B regimen
International
MACOP-B regimen en Espanol MACOP-B regimen en Francais
Business
MACOP-B regimen in the Marketplace Patents on MACOP-B regimen
Experimental / Informatics
List of terms related to MACOP-B regimen

VisualWikitext

Revision as of 15:49, 27 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:MACOP-B Regimen; Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen

Overview

MACOP-B regimen refers to a regimen consisting of methotrexate, doxorubicin (adriamycin), cyclophosphamide, vincristine (Oncovin) and prednisone, bleomycin used to treat aggressive forms of non-Hodgkin's lymphoma.^[1]^[2]

Regimen

MMethotrexate

ADoxorubicin (Adriamycin)

CCyclophosphamide

OVincristine (Oncovin)

PPrednisone

BBleomycin

Indications

Non-Hodgkin's lymphoma^[1]^[3]

==References==

↑ ^1.0 ^1.1 De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E; et al. (2008). "MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma". Int J Radiat Oncol Biol Phys. 72 (4): 1154–60. doi:10.1016/j.ijrobp.2008.02.036. PMID 18472357.
↑ "NCI Thesaurus".
↑ "NCI Thesaurus".

[pmid18472357-1] 1.0 ^1.1 De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E; et al. (2008). "MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma". Int J Radiat Oncol Biol Phys. 72 (4): 1154–60. doi:10.1016/j.ijrobp.2008.02.036. PMID 18472357.

[2] "NCI Thesaurus".

[3] "NCI Thesaurus".

[1]

[2]

[3]

@@ Line 9: / Line 9: @@
 ==Regimen==
 {{chemo|M|Methotrexate}}
 {{chemo|A|Doxorubicin (Adriamycin)}}
 {{chemo|C|Cyclophosphamide}}
 {{chemo|O|Vincristine (Oncovin)}}
@@ Line 20: / Line 21: @@
 {{chemo|B|Bleomycin}}
-==Indications== *[[Non-Hodgkin's lymphoma]]<ref name="pmid18472357">{{cite journal| author=De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E et al.| title=MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. | journal=Int J Radiat Oncol Biol Phys | year= 2008 | volume= 72 | issue= 4 | pages= 1154-60 | pmid=18472357 | doi=10.1016/j.ijrobp.2008.02.036 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18472357 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63457&ns=NCI_Thesaurus }}</ref>
+==Indications==
-  ==References== {{Reflist|2}}  [[Category:Chemotherapy regimens]]
+*[[Non-Hodgkin's lymphoma]]<ref name="pmid18472357">{{cite journal| author=De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E et al.| title=MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. | journal=Int J Radiat Oncol Biol Phys | year= 2008 | volume= 72 | issue= 4 | pages= 1154-60 | pmid=18472357 | doi=10.1016/j.ijrobp.2008.02.036 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18472357 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63457&ns=NCI_Thesaurus }}</ref>
+  ==References==
+{{Reflist|2}}
+[[Category:Chemotherapy regimens]]

MACOP-B regimen: Difference between revisions

Revision as of 15:49, 27 March 2015

Overview

Regimen

Indications

Navigation menu